Agglutinated activity bioassay method for the determination of antivirus potency of Banlangen granula

Yaoxue Xuebao

Volumn 45, Issue 4, 2010, Pages 479-483

  Tang, Hui Ying ^a,b   Yan, Dan ^a   Zhang, Shao Feng ^a,b   Li, Han Bing ^a   Liu, Rong Hua ^b   Xiao, Xiao He ^a  

^a BEIJING 302 HOSPITAL   (China)

^b JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Agglutinated activity; Banlangen granula; Bioassay; Erythrocyte; Quality control

Indexed keywords

CHINESE DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; BANLANGEN GRANULA; BIOASSAY; CHINESE MEDICINE; DRUG DETERMINATION; DRUG POTENCY; DRUG QUALITY; HEMAGGLUTINATION; INFLUENZA VIRUS; METHODOLOGY; NONHUMAN; QUALITY CONTROL; REPRODUCIBILITY;

ANIMALS; ANTIVIRAL AGENTS; BIOLOGICAL ASSAY; DOSAGE FORMS; DRUGS, CHINESE HERBAL; HEMAGGLUTINATION; MALE; NEURAMINIDASE; ORTHOMYXOVIRIDAE; PLANTS, MEDICINAL; QUALITY CONTROL; RABBITS; REPRODUCIBILITY OF RESULTS;

EID: 77951517685     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. China Pharmacopoeia Committee. Pharmacopoeia of the People's Republic of China [S]. Vol I. Beijing: Chemical Industry Press, 2005: 487-488.
2. Xiao XX, Jin C, Zhao ZZ, et al. Probe into innovation and development of pattern of quality control and evaluation for Chinese medicine [J]. China J Chin Mater Med, 2007, 32: 1377-1381.
3. Wang P, Qian ZZ. The readable explanation of the editorial outline of Chinese Pharmacopoeia 2010 edition [J]. Chin J Pharm Anal, 2008, 28: 337-340.
4. Zhang GJ. Bioassay of General Chinese Medicines [M]. Beijing: Chemical Industry Press, 2006: 179.
5. Zhou HJ. Drug Bioassay [M]. Beijing: People's Medical Press, 2005: 9-11.
6. Yamada H. Antiviral compositons containing new glycoprotein from Isatis tinctoria [P]. JP: 1160, 599 [9960, 599], 1999-03-102
7. Lin CW, Tsai FJ, Tsai CH, et al. Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds [J]. Antiviral Res, 2005, 68: 36-42.
8. Hu XC, Zheng WQ. Resistance to Isatia indigotica Fort lectin inhibit influenza virus [J]. J Shanghai Teach Univ, 2003, 32: 62-65.
9. Hu XC, He N, Tang SH. A comparative study on different extraction methods on protein in Isatis indigotica Fort [J]. J Shanghai Teach Univ, 2004, 33: 66-69.
10. Liu SY. Screening on anti-virus efficient composition of Radix Isatidis [J]. J Jiangxi Coll Tradit Chin Med, 1999, 4: 183.
11. Hu XC, Du YH. Progression of research on amino acid analysis in Radix Isatidis [J]. J China-Inter Med Sci, 2004, 4: 130-133.
12. Song ZY, Liu JT. Modern Pharmacology [M]. Beijing: People's Health Press, 1997: 408-409.
13. Sun XX, Zhang LL, Sun CL. The anti-virus effect of an active ingredient from a Chinese traditional herb - Isatis indigotica Fort [J]. Chin Pharm Bull, 2007, 23: 835-836.
14. Cao HP, Tao PZ, Du GH. Establishment and application of high throughput screening model for influenza virus neuraminidase inhibitors in vitro [J]. Acta Pharm Sin, 2002, 37: 930-933.
15. Peng Y, Li WK. Recent development of studies on antivirus phytomedicines in abroad [J]. World Phytomed, 1999, 14: 7.
16. Cann AJ. Virus Culture A Practical Approach [M]. New York: Oxford University Press, 1999: 56-60.
17. World Health Organization. WHO Manual on Animal Influenza Diagnosis and Surveillance [G]. 17-21.
18. Colman PM. Influenza virus neuraminidase: structure, antibodies and inhibitors [J]. Protein Sci, 1994, 3: 1687-1696.
19. Li HB, Yan D, Wang JB, et al. Study on the biological evaluation of Radix Isatidis based on neuraminidase activity assay [J]. Acta Pharm Sin, 2009, 44: 162-166.